MarketsandMarkets Precision Medicine Conference

WHAT TO EXPECT

Overview of Precision Medicine and Genomic Science
Precision Medicine in complex disease prediction and treatment – Chronic diseases, CAR T- cell immunotherapy in solid tumors
Comprehensive Genomic profiling - Single cell sequencing using Liquid biopsy, Genetic screening by nextgeneration sequencing and whole genome sequencing
Use of digital biomarkers for drug development, Multi-Omics prospects (Epigenomics, Proteomics, Transcriptomics, Pharmaco genomics)
Inception of technologies for Precision Medicine – Impact of big data, Artificial intelligence, and Machine Learning, Insilico trials for Precision medicine
Cost benefit issues, Regulatory, Ethical and Social challenges in Precision Medicine
Future purview of Precision Medicine, New beginning – Digital health

Witness live action how precision medicine is revolutionizing the future of healthcare
Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing precision medicine
Discover the different avenues in patient centric care
Comprehend the current and future regulatory prospects for approval of diagnostic tests
Discuss the emerging technologies and opportunities with cutting edge strategies
Opportunity for one-on-one networking with the delegates and extend professional competency
Panel discussion with great lineup of experts

Industry: Pharma/Therapeutic Companies/Start Up’s
CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Immunologists, Geneticists, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology
Academics: Universities, Research Institutes, Hospitals
Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome Note by MarketsandMarkets!	08:50 - 08:55
Opening Remarks by the Chairperson Milena Kalaitsidou, Principal Scientist, Instil Bio	08:55 - 09:00
Precision Medicine in Disease Prediction & Treatment
Keynote Rho kinase (ROCK) as a Therapeutic Target in Cancer Victoria Sanz Moreno, Professor of Cancer Cell Biology, Queen Mary University of London	09:00 - 09:30
Achieving precision medicine in chronic diseases: from patient-focused drug discovery to personalized prediction, prevention, and treatment Sandy Hogg, SVP Alliance Management, PrecisionLife	09:30 - 10:00
Enabling precision medicine: Autoantibody Analysis in Liquid Biopsies Cyndie Forestier, Field Application Scientist, Sengenics	10:00 - 10:30
Morning Refreshments \| One-to-One Networking Meeting	10:30 - 11:20
Precision Medicine Approaches to Tumor Oncology
CAR T-cell immunotherapy of solid tumours: Parallel learning from the clinic and lab John Maher, Scientific Founder and Chief Scientific Officer, Leucid Bio	11:20 - 11:50
Use of tumour-associated antigen targeting Humabodies to deliver CD137 agonism to the tumour microenvironment Andrew Pierce, Vice President, Translational Biology, Crescendo Biologics	11:50 - 12:20
From Cytometry to Tissue Imaging: CyTOF Technology made Straightforward Carole Chedid, Field Application Specialist, Standard BioTools	12:20 - 12:50
RNA Activation in Genetic and Acquired Diseases Nagy Habib, Founder and Head of R&D, MiNA Therapeutics	12:50 - 13:20
Lunch \| One-to-One Networking	13:20 - 14:20
Use of Spatial Transcriptomics to Identify Differentially Expressed Biological Pathways in SEGA Brain Tumours from Patients with Tuberous Sclerosis Complex Hywel Williams, Senior Lecturer in Bioinformatics, School of Medicine, Division of Cancer and Genetics, Cardiff University	14:20 - 14:50
RNA Biomarkers for Human Cancers Arijit Mukhopadhyay, Reader in Human Genetics, University of Salford	14:50 - 15:20
Enhancement of anti-tumour reactivity using a costimulatory antigen receptor (CoStAR) platform: T cell activity tuning Milena Kalaitsidou, Principal Scientist, Instil Bio	15:20 - 15:50
Evening Refreshments \| One-to-One Networking	15:50 - 16:30
Phage-guided delivery of nucleic acid therapeutics in oncology and other human diseases Amin Hajitou, Professor, Chair of Targeted Therapies, Imperial College of London	16:30 - 17:00
Closing Remarks by the Chairperson Milena Kalaitsidou, Principal Scientist, Instil Bio	17:00 - 17:00
Drinks Reception and Networking	17:00 - 17:00
End of Day 1	17:00 - 17:00

Registration	08:15 - 08:50
Welcome Note by MarketsandMarkets	08:50 - 08:55
Opening Remarks by the Chairperson Samaneh Kouchaki, Lecturer, Machine Learning, University of Surrey	08:55 - 09:00
Comprehensive Genomic Profiling
Engineering Gamma Delta T Cells to Supercharge Cytotoxic Function, Persistence, and Safety Caroline Hull, Associate Director, Leucid Bio	09:00 - 09:30
Droplet Microfluidics for personalized cancer therapy Droplet Microfluidics for Personalized Cancer Therapy Christoph A. Merten, , École Polytechnique Fédérale de Lausanne (EPFL)	09:30 - 10:00
Large Scale Implementation of Population Wide Polygenic Risk Scores Manuel Corpas, Scientific Director, Cambridge Precision Medicine	10:00 - 10:30
Morning Refreshments \| One-to-One Networking	10:30 - 11:15
Using digital biomarkers for a precision medicine approach to neuroscience drug development Jennifer Barnett , CEO, Monument Therapeutics	11:15 - 11:45
Unsupervised Data-driven Anomaly Detection and Biomarker Discovery Approach for Detection of Adverse Health Conditions in People Living with Dementia Samaneh Kouchaki, Lecturer, Machine Learning, University of Surrey	11:45 - 12:15
Multi-OMICS led Precision Cardiology- The Model of Heart Failure Dhavendra Kumar, Honorary Clinical Professor, The William Harvey Research Institute, Bart’s School of Medicine & Dentistry, Queen Mary University of London	12:15 - 12:45
Development of Deep-Learning Resources for Computational Histopathology and Outcome Prediction in Oesophageal and Skin Cancer Jun Wang, Senior Lecturer – Bioinformatics, Barts Cancer Institute/ Queen Mary University of London	12:45 - 13:15
Lunch \| One-to-One Networking	13:15 - 14:15
Integrating Health Data into Biobanks for Precision Medicine Ali Abbasi, Visiting Senior Researcher-Precision Medicine, University Medical Center Groningen (UMCG)	14:15 - 14:45
Closing remarks by the Chairperson	14:45 - 14:45
End of Conference	14:45 - 14:45